ELOX 8-K 2026-10-22

Eloxx Pharmaceuticals, Inc. (ELOX) 8-K dated 2026-10-22 — accession 0001193125-26-428116.

Eloxx Pharmaceuticals, Inc. (ELOX) is a biotechnology company listed on US.

Eloxx Pharmaceuticals, Inc. filed a 8-K on 2026-10-22. Accession 0001193125-26-428116.

This 8-K covers: Director/officer change (Item 5.02), Other events (Item 8.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported ELOX revenue for 2025-12-31 was $0. Net income was -$6.0M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. ELOX currently screens at market cap $314.

Not investment advice. The ELOX SEC hub lists recent forms. The stock page is the research view.